ADVANCES IN IMMUNOTHERAPY FOR CANCER TREATMENT

Authors

  • Dr. Bilal Zubair Punjab University, Department of Cancer Biology, Lahore, Pakistan Author

DOI:

https://doi.org/10.71465/hjmri.115

Keywords:

Immunotherapy, Cancer Treatment, Checkpoint Inhibitors, CAR T-cell Therapy, Monoclonal Antibodies, Cancer Vaccines, Immune System, Tumor Microenvironment, Cancer Immunology

Abstract

Immunotherapy has revolutionized cancer treatment by harnessing the body’s immune system to fight cancer cells. Over the last two decades, significant advancements in immunotherapy have led to the development of novel therapies that offer promising results for patients with various types of cancers. These therapies include immune checkpoint inhibitors, monoclonal antibodies, CAR T-cell therapies, and cancer vaccines, all of which have shown substantial efficacy in treating cancers previously deemed incurable. This article reviews the latest advances in cancer immunotherapy, explores the mechanisms by which immunotherapies enhance anti-tumor immunity, and discusses the challenges and future directions for the development of immunotherapeutic strategies. The role of biomarkers in predicting response to immunotherapy and overcoming resistance to treatment is also addressed, along with the future potential of combining immunotherapies with other therapeutic modalities.

Downloads

Published

2025-03-30

Issue

Vol. 5 No. 3 (2025): Holistic Journal of Multidisciplinary Research Innovation

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

All articles published in the Holistic Journal of Multidisciplinary Research Innovation are licensed under an open access model. Authors retain copyright of their work and grant the journal the right of first publication. The content may be freely used, distributed, and reproduced in any medium, provided the original work is properly cited and remains unaltered.